Clinical Trials on Stage III Solid Tumors in Singapore
Total 111 results
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; ASLAN PharmaceuticalsActive, not recruiting
-
National University Hospital, SingaporeKaryopharm Therapeutics IncCompleted
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
National University Hospital, SingaporeCompleted
-
National Cancer Centre, SingaporeRecruiting
-
National University Hospital, SingaporeNatera, Inc.; The N.1 Institute for Health (N.1)Recruiting
-
National University Hospital, SingaporeUnknownSolid Tumor CancerSingapore
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
National University Hospital, SingaporeRecruiting
-
National Cancer Centre, SingaporeCompletedUnspecified Adult Solid Tumor, Protocol SpecificSingapore
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsAustralia, Singapore
-
Kyowa Kirin Co., Ltd.Terminated
-
Otsuka Beijing Research InstituteCompletedMalignant Solid TumourSingapore
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
EDDC (Experimental Drug Development Centre), A*STAR...ParexelRecruiting
-
Singapore General HospitalCompletedSolid Tumor | Histological Type of NeoplasmSingapore
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Taiwan, Spain, Canada, Italy, Singapore, Japan, Hong Kong
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | LymphomasSingapore
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1); Cancer Science Institute of SingaporeNot yet recruitingBreast Cancer | Solid Tumor | Gastrointestinal CancerSingapore
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
National University Hospital, SingaporeTan Tock Seng HospitalUnknownStage III Non-Small Cell Lung CancerSingapore
-
Genentech, Inc.Active, not recruitingSolid TumorsUnited States, Italy, Korea, Republic of, Spain, Denmark, Taiwan, Australia, France, Netherlands, United Kingdom, Singapore, Belgium, Japan, Canada
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
BioNTech SERecruitingSolid TumorUnited States, Spain, Singapore, United Kingdom
-
PfizerCompletedSolid TumorsUnited States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
National Cancer Centre, SingaporeNovartisCompleted
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Novartis PharmaceuticalsCompletedHepatic Impairment | Solid TumorsBelgium, Germany, Netherlands, Italy, Singapore, United States
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 | Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 | Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 | Stage IVC Differentiated Thyroid Gland Carcinoma... and other conditionsUnited States, Taiwan, Australia, Singapore, China
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom